GoodRx Holdings, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
GoodRx Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2019 to Q3 2024.
  • GoodRx Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $4.15M.
  • GoodRx Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $11.6M.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was -$46.7M, a 587% decline from 2022.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $9.6M, a 36.3% decline from 2021.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was $15.1M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $11.6M $4.15M +$12.3M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$618K $4.95M +$51.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$52.3M $1.3M -$5.58M -81.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$46.7M $1.23M +$4.01M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$50.7M -$8.11M -$27.6M -142% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$23.1M -$46.7M -$38M -434% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $14.8M $6.89M +$5.24M +317% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $9.6M -$2.77M -$48.6M -106% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $58.2M $19.5M +$310K +1.62% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $57.8M -$8.74M +$28.6M +76.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $29.3M $1.65M +$14.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $15.1M $45.8M +$53.1M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$38.1M $19.2M +$37M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$75.1M -$37.3M -$45M -587% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$30.1M -$12.6M -$20.3M -262% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$9.83M -$7.36M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$17.9M -$23.6M -412% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $7.66M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $7.77M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 $5.73M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.